Indication
Vancomycin-Resistant Enterococci Infection
1 clinical trial
1 product
Clinical trial
A Phase II Randomized Trial to Evaluate the Impact of Fecal Microbiota Transplantation Using the Penn Microbiome Therapy Products on Recipient and Environmental Colonization With Multidrug-Resistant OrganismsStatus: Not yet recruiting, Estimated PCD: 2026-01-01
Product
PMT